Aurobindo Pharma USA gets FTC nod to buy Lannett

Aurobindo Pharma USA gets FTC nod to buy Lannett.

The acquisition of Lannett Company has received approval from the U.S. Federal Trade Commission, clearing a key regulatory hurdle. This deal significantly expands Aurobindo’s presence in the U.S. generics market. The transaction is expected to close soon, pending final conditions.

📊 STOCKS: AUROPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Mergers